Welcome to LookChem.com Sign In|Join Free

CAS

  • or

323578-56-9

Post Buying Request

323578-56-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4-TERT-BUTOXYCARBONYLAMINO-1-(4-AMINOBENZYL)PIPERIDINE

    Cas No: 323578-56-9

  • No Data

  • No Data

  • No Data

  • HANDE
  • Contact Supplier

323578-56-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 323578-56-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,3,5,7 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 323578-56:
(8*3)+(7*2)+(6*3)+(5*5)+(4*7)+(3*8)+(2*5)+(1*6)=149
149 % 10 = 9
So 323578-56-9 is a valid CAS Registry Number.

323578-56-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 2-amino-1-[(4-aminophenyl)methyl]piperidine-4-carboxylate

1.2 Other means of identification

Product number -
Other names 4-TERT-BUTOXYCARBONYLAMINO-1-(4-AMINOBENZYL)PIPERIDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:323578-56-9 SDS

323578-56-9Downstream Products

323578-56-9Relevant articles and documents

PYRAZOLO-QUINAZOLINE DERIVATIVES AS CHOLINE KINASE INHIBITORS

-

Page/Page column 140; 141, (2019/01/30)

The present invention relates to substituted pyrazolo-quinazoline derivatives which modulate the activity of Choline Kinase (ChoK). The compounds of this invention are therefore useful in treating diseases caused by an altered choline metabolism, such as cancer, cell proliferative disorders, infectious diseases of different origin, immune- related disorders and neurodegenerative disorders. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.

A potent, long-acting, orally active (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors

Mitsuya,Kobayashi,Kawakami,Satoh,Ogino,Kakikawa,Ohtake,Kimura,Hirose,Sato,Numazawa,Hasegawa,Noguchi,Mase

, p. 5017 - 5029 (2007/10/03)

A novel series of (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamides was designed and synthesized based on the structure and biological profiles of an active metabolite 2 of our prototype muscarinic M3 receptor selective antagon

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 323578-56-9